Corcept Therapeutics Inc (NASDAQ:CORT)

Data as of Jan 26
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-26.0M-32.4M-38.0M-46.0M
Total Other Cash Flow2.1M3.4M7.0M9.6M
Funds From Operations-23.8M-28.9M-31.0M-36.3M
Funds From/For Other Operating Expenses-1.6M-1.5M5.0M758.0K
Net Cash Flow - Operating Activities-22.3M-27.4M-36.0M-37.1M
InvestingCapital Expenditures0.00-25.0K-151.0K-127.0K
Net Cash Flow Investing0.00-25.0K-151.0K-127.0K
FinancingShort Term Borrowings0.
Long Term Borrowings0.000.0029.9M0.00
Long Term Debt Reduction-6.0K0.000.00-1.0M
Net Proceeds Stock Sale23.0M42.5M59.7M55.0K
Common Preferred Redeemed0.
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing0.
Net Cash Flow - Financing23.0M42.5M89.6M-970.0K
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
Net Change In Cash711.0K15.1M53.4M-38.2M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.